Impact of EU regulation on UK life sciences further examined
19 April 2016
The Science and Technology Committee questions representatives from medical charities, the regulatory sector and Government on the impact of EU regulation on UK life sciences.
- Watch Parliament TV: Impact of EU regulation on the UK life sciences
- Inquiry: Impact of EU regulation on the UK life sciences
- Science and Technology Committee
Witnesses
Tuesday 19 April 2016, Thatcher Room, Portcullis House
At 2.15pm
- Emma Greenwood, Head of Policy Development, Cancer Research UK
At 2.45pm
- Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency
- Jonathan Mogford, Director of Policy, Medicines and Healthcare products Regulatory Agency
- John Wilkinson, Director of Devices, Medicines and Healthcare products Regulatory Agency
At 3.15pm
- George Freeman MP, Parliamentary Under-Secretary of State for Life Sciences, Department for Business, Innovation and Skills and the Department of Health
Further Information
Image: iStockphoto